Back to Search
Start Over
Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma
- Source :
- Thomson Reuters ONE. January 22, 2025
- Publication Year :
- 2025
-
Abstract
- (GLOBE NEWSWIRE via COMTEX) -- Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma - Approval is [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Thomson Reuters ONE
- Publication Type :
- News
- Accession number :
- edsgcl.824385090